Second-Generation Antipsychotics: Is There Evidence for Sex Differences in Pharmacokinetic and Adverse Effect Profiles?

Author： Aichhorn Wolfgang Whitworth Alexandra B. Weiss Elisabeth M. Marksteiner Josef

ISSN： 0114-5916

Source： Drug Safety, Vol.29, Iss.7, 2006-01, pp. : 587-598

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Switching Between Second-Generation Antipsychotics: Why and How?

By Monika Edlinger Susanne Baumgartner Nadja Eltanaihi-Furtmüller Martina Hummer W. Wolfgang Fleischhacker

CNS Drugs, Vol. 19, Iss. 1, 2005-01 ,pp. : 27-42

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotics: QOL effect in schizophrenia

Inpharma, Vol. 1, Iss. 1453, 2004-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotic AE monitoring adequate?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 650, 2012-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

Second-generation antipsychotic AE monitoring adequate?

Reactions Weekly, Vol. 1, Iss. 1395, 2012-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Effect of Second-Generation Antipsychotics on Employment and Productivity in Individuals with Schizophrenia: An Economic Perspective

By Mauro Percudani

PharmacoEconomics, Vol. 22, Iss. 11, 2004-01 ,pp. : 701-718

Adis International

Access to resources Recommend Favorite